Across the blood-brain barrier: Neurotherapeutic screening and characterization of naringenin as a novel CRMP-2 inhibitor in the treatment of Alzheimer's disease using bioinformatics and computational tools. - Maryam Lawal; Fisayo A. Olotu; Mahmoud E. S. Soliman (Comput. Biol. Medicine, 2018)